Janssen Sciences Ireland to sell $115m rare drug rights

Janssen Sciences Ireland is to sell the rights to a drug that treats a rare disease to UK-based biopharmaceutical firm EUSA Pharma for $115m (€96.6m) in cash.

Janssen Sciences Ireland to sell $115m rare drug rights

By Pádraig Hoare

Janssen Sciences Ireland is to sell the rights to a drug that treats a rare disease to UK-based biopharmaceutical firm EUSA Pharma for $115m (€96.6m) in cash.

You have reached your article limit. Already a subscriber? Sign in

Clubber TV and Irish Examiner logos in offer banner

Every Match. Every Story.

One Ultimate Bundle

No obligation. Ts&Cs apply.

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited